💨 Abstract

A study at the University of Gothenburg suggests a novel method for treating type 1 diabetes by blocking the somatostatin hormone to prevent harmful blood glucose dips. In type 1 diabetes, the hormone somatostatin is released in excess, inhibiting the release of glucagon, which aids in maintaining normal blood sugar levels.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖